Cargando…

The Genetic Basis of Graves' Disease

The presented comprehensive review of current knowledge about genetic factors predisposing to Graves’ disease (GD) put emphasis on functional significance of observed associations. In particular, we discuss recent efforts aimed at refining diseases associations found within the HLA complex and impli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Płoski, Rafał, Szymański, Konrad, Bednarczuk, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271308/ https://www.ncbi.nlm.nih.gov/pubmed/22654555 http://dx.doi.org/10.2174/138920211798120772

Ejemplares similares

Association between Polymorphisms in the TSHR Gene and Graves' Orbitopathy
por: Jurecka-Lubieniecka, Beata, et al.
Publicado: (2014)

Differences in Gene-Gene Interactions in Graves’ Disease Patients Stratified by Age of Onset
por: Jurecka-Lubieniecka, Beata, et al.
Publicado: (2016)

Challenges and perspectives of selenium supplementation in Graves’ disease and orbitopathy
por: Bednarczuk, Tomasz, et al.
Publicado: (2019)

The importance of an individual approach to Graves’ hyperthyroidism
por: Bednarczuk, Tomasz
Publicado: (2015)

Association between Age at Diagnosis of Graves' Disease and Variants in Genes Involved in Immune Response
por: Jurecka-Lubieniecka, Beata, et al.
Publicado: (2013)

Thyroid Stimulating Hormone Receptor (TSHR) Intron 1 Variants Are Major Risk Factors for Graves' Disease in Three European Caucasian Cohorts
por: Płoski, Rafał, et al.
Publicado: (2010)

Association of polymorphism in genes encoding κB inhibitors (IκB) with susceptibility to and phenotype of Graves' disease: a case-control study
por: Kurylowicz, Alina, et al.
Publicado: (2009)

Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
por: Rymuza, Joanna, et al.
Publicado: (2018)

Blood Pressure Profile and N-Terminal-proBNP Dynamics in Response to Intravenous Methylprednisolone Pulse Therapy of Severe Graves’ Orbitopathy
por: Miskiewicz, Piotr, et al.
Publicado: (2018)

An Intronic HCP5 Variant Is Associated With Age of Onset and Susceptibility to Graves Disease in UK and Polish Cohorts
por: Lane, Laura Claire, et al.
Publicado: (2020)

Clinical utility of TSH receptor antibody levels in Graves’ orbitopathy: a comparison of two TSH receptor antibody immunoassays
por: Bluszcz, Gabriela A., et al.
Publicado: (2018)

High-dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII
por: Miśkiewicz, P., et al.
Publicado: (2018)

Graves of Graves' Disease, 1796—1853
por: Taylor, Selwyn
Publicado: (1986)

Contemporary role of medical genetics in internal medicine
por: Saracyn, Marek, et al.
Publicado: (2013)

Genetic associations of the thyroid stimulating hormone receptor gene with Graves diseases and Graves ophthalmopathy: A meta-analysis
por: Xiong, Haibo, et al.
Publicado: (2016)

The Role of the Microbiota in Graves’ Disease and Graves’ Orbitopathy
por: Hou, Jueyu, et al.
Publicado: (2021)

The genetic basis of disease
por: Jackson, Maria, et al.
Publicado: (2018)

The Influence of Juvenile Graves' Ophthalmopathy on Graves' Disease Course
por: Jankauskiene, Jurate, et al.
Publicado: (2017)

Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
por: Lanzolla, G., et al.
Publicado: (2022)

Genetic Polymorphism of Human Y Chromosome and Risk Factors for Cardiovascular Diseases: A Study in WOBASZ Cohort
por: Kostrzewa, Grażyna, et al.
Publicado: (2013)

Graves' Disease
Publicado: (1895)

Graves’ Disease
por: Bailey, William C.
Publicado: (1886)

Advances in genetic hearing loss: CIB2 gene
por: Jacoszek, Agnieszka, et al.
Publicado: (2016)

Graves’ disease and Graves’ orbitopathy following COVID-19
por: Lanzolla, G., et al.
Publicado: (2021)

Hashimoto’s Thyroiditis and Graves’ Disease in Genetic Syndromes in Pediatric Age
por: Casto, Celeste, et al.
Publicado: (2021)

The Treatment of Graves' Disease
por: Herapath, C. E. K.
Publicado: (1930)

Simultaneous induction of Graves’ hyperthyroidism and Graves’ ophthalmopathy by TSHR genetic immunization in BALB/c mice
por: Xia, Nan, et al.
Publicado: (2017)

Microchimerism in Graves' Disease
por: Galofré, Juan C.
Publicado: (2012)

The Genetic Basis of Moyamoya Disease
por: Mertens, R., et al.
Publicado: (2021)

Deciphering the genetic basis of microcystin tolerance
por: Schwarzenberger, Anke, et al.
Publicado: (2014)

Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease
por: Jarusaitiene, Dalia, et al.
Publicado: (2016)

Advances in Graves' Disease
por: Galofré, Juan C., et al.
Publicado: (2012)

The Treatment of Graves's Disease
Publicado: (1906)

The Etiology of Graves's Disease
por: Carter, Godfrey
Publicado: (1899)

On Œdema in Graves's Disease
por: Mackenzie, Hector
Publicado: (1897)

Unilateral Graves' Disease
por: Mahalakshmi, VNSSVAMS D, et al.
Publicado: (2019)

Graves Disease in Infancy
por: Beliard, Kara A, et al.
Publicado: (2021)

Value of multilocus genetic risk score for atrial fibrillation in end-stage kidney disease patients in a Polish population
por: Saracyn, Marek, et al.
Publicado: (2018)

The Genetic Basis for Human Disease
por: Seashore, Margretta R.
Publicado: (1980)

Correction: The genetic basis of disease
por: Jackson, Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l8jlvev4holg2dobust9ope01j